COPENHAGEN, Denmark--(BUSINESS WIRE)--COLOTECT™ 3.0 is a non-invasive colorectal cancer screening test developed by BGI, and will be launched in early 2023. BGI plans to release pre-clinical ...
COLOTECT 3.0 ist ein von BGI entwickelter nicht-invasiver Test zur Darmkrebsfrüherkennung, der Anfang 2023 auf den Markt kommen wird. BGI plant, auf dem Gastrointestinal Cancers Symposium 2023 der ...
Recently, BGI Genomics' COLOTECT ™ 1.0 DNA Methylation Detection Kit for Human SDC2, ADHFE1, and PPP2R5C Genes (Real-Time PCR), Sample Pretreatment Kit for Methylation Detection, DNA Isolation Kit, ...
Bangkok, Thailand, 25 November 2022 (ANTARA/Xinhua-AsiaNet) - COLOTECT adalah tes self-sampling kanker kolorektal non-invasif (CRC) yang dapat mendeteksi status ...
SAN FRANCISCO, Feb. 7, 2023 /PRNewswire/ -- COLOTECT 3.0, a multi-target fecal DNA test outperforms fecal immunochemical tests (FIT) in terms of detection of colorectal cancer and advanced ...
Hosted on MSN
华大基因与泰国卫生部、兴泰基因正式签署COLOTECT™合作备忘录
5月19日，据华大基因（300676.SZ）消息，近日，华大基因与泰国卫生部医疗科技司、华大基因泰国合资公司兴泰基因正式签署中泰DNA甲基化结直肠癌早筛及肠道微生态联合研究合作备忘录，依托华 ...
香港 - Media OutReach - 2022年11月28日 - COLOTECT檢測試劑盒已獲取香港表列註冊證書。COLOTECT是一種無創的結直腸癌（CRC）自採樣檢測，可檢測腸道脫落細胞基因的甲基化狀態，幫助篩查結直腸癌和癌 ...
HONG KONG SAR – Media OutReach – 28 November 2022 – COLOTECT™ Test Kit has obtained the Certificate of IVD from HKSAR Department of Health.COLOTECT™ is a non-invasive colorectal cancer (CRC) ...
When 70-year-old Hanka Kowalski from Pruszków, a small city in Central Poland, received the results from a simple and non-invasive DNA test, she was stunned—it came back positive for early-stage ...
COLOTECT" 3.0 ist ein von BGI entwickelter nicht-invasiver Test zur Darmkrebsfrüherkennung, der Anfang 2023 auf den Markt kommen wird. BGI plant, auf dem Gastrointestinal Cancers Symposium 2023 der ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results